Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares stood at 1.15 million during the latest session, with the company’s beta value hitting 2.55. At the last check today, the stock’s price was $5.48, to imply a decrease of -3.77% or -$0.22 in intraday trading. The BDTX share’s 52-week high remains $6.85, putting it -25.0% down since that peak but still an impressive 73.91% since price per share fell to its 52-week low of $1.43. The company has a valuation of $283.68M, with an average of 607.28K shares over the past 3 months.

Black Diamond Therapeutics Inc (NASDAQ:BDTX) trade information

After registering a -3.77% downside in the latest session, Black Diamond Therapeutics Inc (BDTX) has traded red over the past five days. The stock hit a weekly high of 6.21, dropping -3.77% in its intraday price action. The 5-day price performance for the stock is -1.53%, and 18.46% over 30 days. With these gigs, the year-to-date price performance is 95.19%.

Black Diamond Therapeutics Inc (BDTX) estimates and forecasts

Looking at statistics comparing Black Diamond Therapeutics Inc share performance against respective industry, we note that the company has underperformed competitors. Black Diamond Therapeutics Inc (BDTX) shares are 134.40% up over the last 6 months, with its year-to-date growth rate lower than industry average at 9.04% against 9.60%.

BDTX Dividends

Black Diamond Therapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Black Diamond Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.